Dialysis Cannot be Dosed

Seminars in Dialysis

Volumn 24, Issue 5, 2011, Pages 471-479

  Meyer, Timothy W ^a   Sirich, Tammy L ^a   Hostetter, Thomas H ^b  

^a STANFORD UNIVERSITY   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMODIALYSIS FLUID; PLASMA PROTEIN; UREA;

EDITORIAL; HUMAN; METABOLISM; METHODOLOGY; RENAL REPLACEMENT THERAPY;

BLOOD PROTEINS; HEMODIALYSIS SOLUTIONS; HUMANS; RENAL DIALYSIS; UREA;

EID: 80054690187     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2011.00979.x     Document Type: Editorial

References (68)

1. Hemodialysis Adequacy 2006 Work Group: Clinical practice guidelines for hemodialysis adequacy, update 2006. Am J Kidney Dis 48(Suppl 1):S2-S90, 2006
2. Depner TA: Prescribing Hemodialysis: A Guide to Urea Modeling. Norwall, MA: Kluwer Academic Publishers, 1991
3. Lowrie EG, Laird NM, Parker TF, Sargent JA: Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176-1181, 1981
4. Burton BT: Adequacy of dialysis. Introduction: purpose of the conference. Kidney Int 7(Suppl 2):S1, 1975
5. Teschan PE: Electroencephalographic and other neurophysiological abnormalities in uremia. Kidney Int 7(Suppl 2):S210-S216, 1975
6. Tyler HR: Neurological aspects of uremia: an overview. Kidney Int 7(Suppl 2):S188-S193, 1975
7. Sargent JA, Gotch FA: The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int 7(Suppl 2):S35-S44, 1975
8. Scribner BH, Babb AL: Evidence for toxins of "middle" molecular weight. Kidney Int 7(Suppl 2):349-351, 1975
9. Henderson LW, Ford C, Colton CK, Bluemle LW, Bixler HJ: Uremic blood cleansing by diafiltration using a hollow fiber ultrafilter. Trans Am Soc Artif Intern Organs 16:107-112, 1970
10. Gotch FA, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526-534, 1985
11. Schreiner G, Maher J: Biochemistry of Uremia, in Uremia. Springfield, IL: Charles Thomas, 1960
12. Johnson WJ, Hagge WW, Wagoner RD, Dinapoli RP, Rosevear JW: Effects of urea loading in patients with far-advanced renal failure. Mayo Clin Proc 47:21-29, 1972
13. Vanholder R, De Smet R, Glorieux G, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Lemke HD, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W: Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63:1934-1943, 2003
14. Depner TA: "Artificial" hemodialysis versus "natural" hemofiltration. Am J Kidney Dis 52:403-406, 2008
15. Thomas G, Jaber BL: Convective therapies for removal of middle molecular weight uremic toxins in end-stage renal disease: a review of the evidence. Semin Dial 22:610-614, 2009
16. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010-2019, 2002
17. Gulyassy PF: Can dialysis remove protein bound toxins that accumulate because of renal secretory failure? ASAIO J 40:92-94, 1994
18. Jourde-Chiche N, Dou L, Cerini C, Dignat-George F, Vanholder R, Brunet P: Protein-bound toxins - update 2009. Semin Dial 22:334-339, 2009
19. Meijers BK, Bammens B, Verbeke K, Evenepoel P: A review of albumin binding in CKD. Am J Kidney Dis 51:839-850, 2008
20. Lesaffer G, De Smet R, Lameire N, Dhondt A, Duym P, Vanholder R: Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. Nephrol Dial Transplant 15:50-57, 2000
21. Meyer TW, Leeper EC, Bartlett DW, Depner TA, Lit YZ, Robertson CR, Hostetter TH: Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes. J Am Soc Nephrol 15:1927-1935, 2004
22. Niwa T: Indoxyl sulfate is a nephro-vascular toxin. J Ren Nutr 20:S2-S6, 2010
23. Meijers BK, Van Kerckhoven S, Verbeke K, Dehaen W, Vanrenterghem Y, Hoylaerts MF, Evenepoel P: The uremic retention solute p-cresyl sulfate and markers of endothelial damage. Am J Kidney Dis 54:891-901, 2009
24. Roch-Ramel F, Besseghir K, Murer H: Renal excretion and tubular transport of organic anions and cations. In: Windhager E (ed.). Handbook of Physiology, Section 8: Renal Physiology Oxford: Oxford University Press, 1992:2188-2262
25. Kult J, Stapf E: Changing emphasis in modern hemodialysis therapies: cost-effectiveness of delivering higher doses of dialysis. Int J Artif Organs 30:577-582, 2007
26. Bhimani JP, Ouseph R, Ward RA: Effect of increasing dialysate flow rate on diffusive mass transfer of urea, phosphate and beta2-microglobulin during clinical haemodialysis. Nephrol Dial Transplant 25:3990-3995, 2010
27. Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW: Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. Am J Kidney Di 53:1042-1049, 2009
28. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y: Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. Am J Kidney Dis 44:278-285, 2004
29. Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH: Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18:868-874, 2007
30. Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R: Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 24:562-570, 2009
31. Depner TA: Uremic toxicity: urea and beyond. Semin Dial 14:246-251, 2001
32. Schneditz D, Daugirdas JT: Compartment effects in hemodialysis. Semin Dial 14:271-277, 2001
33. Heaf JG, Jensen SB, Jensen K, Ali S, von Jessen F: The cellular clearance theory does not explain the post-dialytic small molecule rebound. Scand J Urol Nephrol 32:350-355, 1998
34. Schneditz D, Platzer D, Daugirdas JT: A diffusion-adjusted regional blood flow model to predict solute kinetics during haemodialysis. Nephrol Dial Transplant 24:2218-2224, 2009
35. Depner TA, Rizwan S, Cheer AY, Wagner JM, Eder LA: High venous urea concentrations in the opposite arm. A consequence of hemodialysis-induced compartment disequilibrium. Trans Am Soc Artif Intern Organs 37:M141-M143, 1991
36. Ziolko M, Pietrzyk JA, Grabska-Chrzastowska J: Accuracy of hemodialysis modeling. Kidney Int 57:1152-1163, 2000
37. Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R: Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 67:1566-1575, 2005
38. Ponda MP, Quan Z, Melamed ML, Raff A, Meyer TW, Hostetter TH: Methylamine clearance by haemodialysis is low. Nephrol Dial Transplant 25:1608-1613, 2009
39. Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R: Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50:279-288, 2007
40. Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during hemodialysis: evidence for biphasic regulation. Kidney Int 61:655-667, 2002
41. Charra B, Terrat JC, Vanel T, Chazot C, Jean G, Hurot JM, Lorriaux C: Long thrice weekly hemodialysis: the Tassin experience. Int J Artif Organs 27:265-283, 2004
42. Tattersall JE, DeTakats D, Chamney P, Greenwood RN, Farrington K: The post-hemodialysis rebound: predicting and quantifying its effect on Kt/V. Kidney Int 50:2094-2102, 1996
43. Depner T, Beck G, Daugirdas J, Kusek J, Eknoyan G: Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose. Am J Kidney Dis 33:142-149, 1999
44. Daugirdas JT, Greene T, Depner TA, Leypoldt J, Gotch F, Schulman G, Star R: Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO Study. J Am Soc Nephrol 15:194-203, 2004
45. Leypoldt JK, Cheung AK: Revisiting the hemodialysis dose. Semin Dial 19:96-101, 2006
46. Gotch FA: Is Kt/V urea a satisfactory measure for dosing the newer dialysis regimens? Semin Dial 14:15-17, 2001
47. Leypoldt JK, Jaber BL, Zimmerman DL: Predicting treatment dose for novel therapies using urea standard Kt/V. Semin Dial 17:142-145, 2004
48. Daugirdas JT, Depner TA, Greene T, Levin NW, Chertow GM, Rocco MV: Standard Kt/V urea: a method of calculation that includes effects of fluid removal and residual kidney clearance. Kidney Int 77:637-644, 2010
49. Casino FG, Lopez T: The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:1574-1581, 1996
50. Depner TA, Bhat A: Quantifying daily hemodialysis. Semin Dial 17:79-84, 2004
51. Lopot F, Nejedly B, Sulkova S: Physiology in daily hemodialysis in terms of the time average concentration/time average deviation concept. Hemodial Int 8:39-44, 2004
52. Gotch F: The basic, quantifiable parameter of dialysis prescription is Kt/V urea; treatment time is determined by the ultrafiltration requirement; all three parameters are of equal importance. Blood Purif 25:18-26, 2007
53. Section II. Haemodialysis adequacy. Nephrol Dial Transplant 17(Suppl 7):16-31, 2002
54. Marquez IO, Tambra S, Luo FY, Li Y, Plummer NS, Hostetter TH, Meyer TW: Contribution of residual function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:290-296, 2011
55. Cooper BA, Branley P, Bulfone L, Collins JF, Craig JC, Fraenkel MB, Harris A, Johnson DW, Kesselhut J, Li JJ, Luxton G, Pilmore A, Tiller DJ, Harris DC, Pollock CA: A randomized, controlled trial of early versus late initiation of dialysis. New Engl J Med 363:609-619, 2010
56. Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G: Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO Study. J Am Soc Nephrol 17:546-555, 2006
57. Ward RA, Greene T, Hartmann B, Samtleben W: Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration. Kidney Int 69:1431-1437, 2006
58. Schmidt-Nielsen K: Scaling: Why is animal size so important? Cambridge, Cambridge University Press, 1984
59. Singer MA, Morton AR: Mouse to elephant: biological scaling and Kt/V. Am J Kidney Dis 35:306-309, 2000
60. Beuchat CA: Structure and concentrating ability of the mammalian kidney: correlations with habitat. Am J Physiol 271:R157-R179, 1996
61. Sarkar SR, Kuhlmann MK, Kotanko P, Zhu F, Heymsfield SB, Wang J, Meisels IS, Gotch FA, Kaysen GA, Levin NW: Metabolic consequences of body size and body composition in hemodialysis patients. Kidney Int 70:1832-1839, 2006
62. Spalding EM, Chandna SM, Davenport A, Farrington K: Kt/V underestimates the hemodialysis dose in women and small men. Kidney Int 74:348-355, 2008
63. Evenepoel P, Meijers BK, Bammens BR, Verbeke K: Uremic toxins originating from colonic microbial metabolism. Kidney Int 76(Suppl 114):S12-S19, 2009
64. Schepers E, Glorieux G, Vanholder R: The gut: the forgotten organ in uremia? Blood Purif 29:130-136, 2010
65. Aronov P, Luo FY, Plummer NS, Quan Z, Hostetter TH, Meyer TW: The multiplicity of colon-derived uremic solutes. J Am Soc Nephrol 2011 [ePub ahead of print]
66. Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P: p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25:219-224, 2009
67. Martinez AW, Recht NS, Hostetter TH, Meyer TW: Removal of p-cresol sulfate by hemodialysis. J Am Soc Nephrol 16:3430-3436, 2005
68. Walther JL, Bartlett DW, Chew W, Robertson CR, Hostetter TH, Meyer TW: Downloadable computer models for renal replacement therapy. Kidney Int 69:1056-1063, 2006